Review
Published on 27 Jun 2023
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1183727
- 6,887 views
- 6 citations
Type at least 3 characters
2,748 articles
Articles
Original Research
Published on 27 Jun 2023
Computational formulation of a multiepitope vaccine unveils an exceptional prophylactic candidate against Merkel cell polyomavirus
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1160260
- 3,573 views
- 9 citations
Original Research
Published on 26 Jun 2023
Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1203410
- 8,209 views
- 17 citations
Original Research
Published on 26 Jun 2023
Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1188431
- 3,691 views
- 2 citations
Original Research
Published on 26 Jun 2023
Impact of maternal whole-cell or acellular pertussis primary immunization on neonatal immune response
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1192119
- 2,835 views
Editorial
Published on 22 Jun 2023
Editorial: Immunogenicity and toxicity of AAV gene therapy
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1227231
- 3,137 views
- 2 citations
Original Research
Published on 21 Jun 2023
A promising self-nanoemulsifying adjuvant with plant-derived saponin D boosts immune response and exerts an anti-tumor effect
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1154836
- 2,848 views
- 2 citations
Original Research
Published on 21 Jun 2023
Self-assembled ferritin nanoparticles displaying PcrV and OprI as an adjuvant-free Pseudomonas aeruginosa vaccine
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1184863
- 3,617 views
- 3 citations
Original Research
Published on 20 Jun 2023
Umbilical cord-mesenchymal stem cells induce a memory phenotype in CD4+ T cells
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1128359
- 5,098 views
- 4 citations
Brief Research Report
Published on 19 Jun 2023
OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1188605
- 4,082 views
- 12 citations
Original Research
Published on 19 Jun 2023
Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1160065
- 8,861 views
- 4 citations
Original Research
Published on 19 Jun 2023
A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1174379
- 1,567 views
- 2 citations
Original Research
Published on 19 Jun 2023
Safety and efficacy of dendritic cell vaccine for COVID-19 prevention after 1-Year follow-up: phase I and II clinical trial final result
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1122389
- 3,343 views
- 1 citation
Original Research
Published on 16 Jun 2023
Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1178688
- 4,021 views
- 1 citation
Opinion
Published on 15 Jun 2023
Quantum vaccinomics platforms to advance in vaccinology
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1172734
- 2,980 views
- 5 citations
Original Research
Published on 14 Jun 2023
Rapid nanobody-based imaging of mesothelin expressing malignancies compatible with blocking therapeutic antibodies
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1200652
- 4,291 views
- 2 citations